The active ingredient is generated by isotopes and the cause it not yet clear and the FDA stated it has not ruled out manufacturing facilities in their research. Doctors should stop using the drug according to the FDA warning. BD
Positron emission tomography (PET) scan drug CardioGen-82 may cause increased radiation exposure, the Food and Drug Administration announced Tuesday, and the agency is warning doctors to stop using the drug.
The drug, manufactured by Italian company Bracco Diagnostics Inc., is used in positron emission tomography scans to diagnose heart disease. On July 15 the FDA found that two patients who had undergone these scans months earlier had detectable levels of radiation.